Frazier Healthcare VI

Frazier Healthcare VI is a venture capital fund managed by Frazier Healthcare Partners, which was established in 1991 and is based in Seattle, Washington. The firm specializes in providing growth capital to companies within the healthcare sector, focusing on areas such as pharmaceuticals, biotechnology, medical devices, healthcare services, and life sciences. Frazier Healthcare VI invests across all stages of a company's development, from early-stage ventures to later-stage growth buyouts. The firm typically makes investments ranging from $3 million to $100 million, with a preference for companies that demonstrate profitability and have revenues between $50 million and $500 million. Frazier Healthcare Partners has a strong track record, having invested in over 170 healthcare companies and actively contributing to their growth through strategic guidance and leveraging extensive industry networks. The firm seeks opportunities primarily in the United States, Canada, and Europe, emphasizing its commitment to addressing unmet medical needs through innovation.

Robert Ang

Senior Associate

Kent Berkley

Partner

Clarissa Berman

Vice President

Jamie Brush

Senior Associate

James Brush

General Partner and Portfolio Manager

Joe Cabral

Senior Associate

Murphy (Andy) Caine

Partner and COO of CoE

Albert Cha

Managing Partner

James D'Onofrio

Senior Associate

Chris Davidge

Associate

Anthony Draye

CoE - Partner, Technology and Innovation

Danica Elliott

Investor

Daniel Estes

General Partner

Nathan Every

General Partner

Daniel Ewnetu

Associate

Volodymyr Gulidov

Associate

Anna Hamm

Associate

Tanya Hayes

CoE - Partner, Human Capital and ESG

Matt Hinshaw

Vice President

Jeremy Janson

Principal

Aditya Kohli

Venture Partner

Kevin Li

Principal

Ryan Lucero

Partner

Michael Machak

Senior Associate

Ben Magnano

Managing Partner

Angel Martin

Associate

Nader J. Naini

Managing Partner

Julian Nikochev

Venture Partner

Max M. Nowicki

Senior Associate

Luke Ostrander

Associate

Christina Miller Reszka

Partner

Jack Stephenson

Associate

Shyamal Swami

Principal

Steven Tallman

Operating Partner

James Topper

General Partner

James Topper

Managing Partner

Jack Trunzo

Vice President

Joe Whitters

Executive Partner

Andrew Wu

Senior Associate

Eric Yang

Associate

Jennifer Zhuang

Senior Associate

Anna Chen Ph.D

Principal

James Topper Ph.D

Managing Partner

Past deals in Macau

SanReno Therapeutics

Funding Round in 2021
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies in the People’s Republic of China, Hong Kong, Macau, Taiwan and Singapore (the “Territory”). SanReno Therapeutics formed with JV of Chinook Therapeutics and Frazier Healthcare Partners and Pivotal bioVenture Partners China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.